Abstract
Individualization of multiple sclerosis treatment – case report
- Studenckie Koło Naukowe „Neurologia”, Uniwersytet Technologiczno-Humanistyczny im. Kazimierza Pułaskiego w Radomiu, Radom, Polska; Kazimierz Pulaski University of Technology and Humanities in Radom, Radom, Poland
- Klinika Neurologii, Mazowiecki Szpital Specjalistyczny w Radomiu, Radom, Polska; Neurology Clinic, Masovian Specialist Hospital in Radom, Radom, Poland
Objectives.
Multiple sclerosis is the most common inflammatory-demyelinating disease of the CNS and the most common cause of disability among young people. The individualisation of therapy leads to better treatment results and makes it possible to increase compliance, i.e., the patient’s adherence to the recommendations given. Adherence, i.e., cooperation between the patient and the doctor, is equally important. The patient has a decisive influence on the choice of treatment.
Case report.
A 27-year-old man with relapsing-remitting MS diagnosed in 2013 has been presenting with pyramidal-cerebellar syndrome since the onset of the disease. The patient underwent unsuccessful treatment with interferon beta-1a, glatiramer acetate, dimethyl fumarate, and teriflunomide. Individual treatments were discontinued by the patient due to side effects of the drugs. The presented case report is an example of the high effectiveness of induction therapy followed by escalation treatment.
Conclusions.
The patient-doctor relationship is crucial in the treatment process.
Keywords
multiple sclerosis, individualization of therapy, treatment of multiple sclerosis, management of multiple sclerosis
Integrated with
